Your message was sent. You'll receive a response shortly. Midway through 2024, Audi overhauled its Q4 e-Tron lineup, ditching the electric compact SUV’s rear-drive base variant and bolstering ...

Asian Paints Share Price: Asian Paints shares rose 3% to Rs 2,792 despite Q4 results missing estimates, with a 2% YoY increase in net profit to Rs 1,257 crore. Brokerages maintain a 'sell' view due to ...

$7.1B GAAP operating income in 2024; $1.6B in Q4 $7.1B GAAP net income in 2024; $2.3B in Q4 incl. $0.6B mark-to-market gain on digital assets $8.4B non-GAAP net income1 in 2024; $2.6B in Q4 Q4 was ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Intel (INTC) announced its fourth quarter earnings on Thursday, beating estimates on the top and bottom lines but falling short on Q1 guidance. Still, the company said its nascent foundry business ...

On today’s exciting episode of Quick Charge, we explore the Tesla Q4 earnings call’s high-level weirdness, including the impact Bitcoin had on the bottom line, what it means for stock prices ...

Q4 bank earnings are expected to decline moderately from Q3 yet show year-over-year increases, as interest rates stay relatively elevated even with the Federal Reserve cutting rates by 100 basis ...

Tesla (TSLA) released its financial results and shareholders letter for the fourth quarter (Q4) and full-year 2024 after market close today. We are updating this post with all the details from the ...

Joining the evolving line of Audi BEVs at the turn of the decade, the Audi Q4 e-tron served as the brand’s electric entry point. Riding on the same MEB architecture that underpins its more cost ...

Facebookparent Meta reported a surge in revenue and profit in the fourth quarter (Q4) of FY24, driven by strong digital advertising spend. The California-based firm’s net profit surged 49% ...

Danaher's Q4 adjusted EPS missed estimates, while sales of $6.54B exceeded forecasts, driven by biotech and life sciences growth. The diagnostics segment saw a 3% decline, impacting overall ...

AbbVie Q4 adjusted EPS of $2.16 beat estimates, with strong sales of Skyrizi (+57.9%) and Rinvoq (+47.1%) boosting revenue growth. AbbVie raises 2027 revenue forecast for Skyrizi and Rinvoq to $31 ...